To investigate the regulatory roles of ASIC1a and RIPK3 in arthritis, we treated CIA mice with the ASIC1a-specific inhibitor PcTX1, the non-specific inhibitor Amiloride, and the RIPK3-specific inhibitor GSK872 (Figure 7A). Here, RIPK3 is linked to arthritic joint disease.